Renal Cancer - Results from #6900

The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus - Abstract June 14, 2014

Surgical management of metastatic renal cell carcinoma in the era of targeted therapies - Abstract June 14, 2014

Mucinous tubular and spindle cell carcinoma of the kidney with prominent papillary component, a non-classic morphologic variant. A histologic, immunohistochemical, electron microscopic and fluorescence in situ hybridization study - Abstract June 13, 2014

The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): Focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation - Abstract June 12, 2014

Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies - Abstract June 12, 2014

Acute aortic dissection in a patient receiving multiple tyrosine kinase inhibitors for 5 years - Abstract June 12, 2014

The impact of smoking on survival in renal cell carcinoma: A systematic review and meta-analysis - Abstract June 11, 2014

Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma - Abstract June 11, 2014

Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma - Abstract June 11, 2014

Radiotherapy for renal-cell carcinoma - Abstract June 11, 2014

First-, second-, third-line therapy for mRCC: Benchmarks for trial design from the IMDC - Abstract June 11, 2014

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: Preliminary results from the Danish Renal Cancer Group Study-1 - Abstract June 9, 2014

Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer - Abstract June 9, 2014

MRI phenotype in renal cancer: Is it clinically relevant? - Abstract June 9, 2014

Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment - Abstract June 6, 2014

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study - Abstract June 6, 2014

Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice - Abstract June 6, 2014

Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib - Abstract June 5, 2014

Strategies for the management of adverse events associated with mTOR inhibitors - Abstract June 5, 2014

Transitional cell carcinoma arising in a calyceal cyst mimicking a cystic renal tumour - Abstract June 5, 2014

Page 346 of 457